Articles related to Family Medicine/General Practice

In this podcast/article from KevinMD, the implications of long COVID (the symptoms occurring more than three weeks after infection, also known as post-acute COVID syndrome) – specifically focused on post-viral fatigue syndrome (PVFS) – are examined, as the inability to tolerate a glass of wine or a bottle of beer could be an important clue to its true diagnosis.

With 1 in 5 COVID-19 patients receiving a psychiatric diagnosis within 90 days of their COVID diagnosis, it’s obvious the pandemic is wreaking havoc on the population’s mental health, whether its anxiety disorders, insomnia, losing a loved one, losing a job, caring for the sick, or all of the above. Learn what you and your patients can do to protect and manage mental health during these trying times.

Anaphylaxis to the mRNA COVID-19 vaccines is currently estimated to occur in 2.5 to 11.1 cases per million doses, largely in individuals with a history of allergy. In this JAMA “Research Letter”, the authors investigated acute allergic reaction incidence with more than 60,000 mRNA COVID-19 vaccine administrations at Mass General Brigham (MGB).

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) are cornerstones of cardiovascular disease therapy. In this article (registration required) from the Cleveland Clinic Journal of Medicine, the author provides insight and commentary on whether ACE inhibitors are better than ARBs. The conclusion is there is more to the story and the evidence than you may think.

From MedPage Today comes this inspirational story about Christopher Veal, a medical student at UVM’s Larner College of Medicine who is calling on medical school leaders to change their culture and adjust their programs to screen for suicidal ideation and mental health early on in student life. Veal decided to speak up after a friend and fellow med student took his own life, as Veal once attempted.

There are more than 20,000 drugs approved for sale in the United States, and over the course of time, the sales of these drugs ebb and flow based on many factors. But some stay the course of time and reveal new indications or uses based on renewed clinical research. Here are five “old” drugs that are enjoying a renaissance right now, including thalidomide and its long, dark history.